Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more than $10 billion following a heated takeover battle.
Source link
About The Author
Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle